Innovus Meditech Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 6 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.50 M
- Revenue Growth 112.58%
- Profit Growth 206.93%
- Ebitda 8.45%
- Net Worth 50.84%
- Total Assets 6.62%
About Innovus Meditech
Innovus Meditech Private Limited (IMPL) is a Private Limited Indian Non-Government Company incorporated in India on 27 March 2018 (Six years and ten months 13 days old ). Its registered office is in Chennai, Tamil Nadu, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹3.50 M.
Balakrishnan Prakash and Anandan Anbazhagan serve as directors at the Company.
Company Details
-
Location
Chennai, Tamil Nadu, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U74999TN2018PTC121768
-
Company No.
121768
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
27 Mar 2018
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Chennai
Industry
Who are the key members and board of directors at Innovus Meditech?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Balakrishnan Prakash
|
Director | 27-Mar-2018 | Current |
|
Anandan Anbazhagan
|
Director | 26-Jun-2023 | Current |
Financial Performance of Innovus Meditech.
Innovus Meditech Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 112.58% increase. The company also saw a substantial improvement in profitability, with a 206.93% increase in profit. The company's net worth Soared by an impressive increase of 50.84%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Innovus Meditech?
Unlock access to Innovus Meditech's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Gelidcure Healthcare Private LimitedBalakrishnan Prakash and Anandan Anbazhagan are mutual person
Charges (Loans)
₹3.50 M
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 0.35 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 09 Dec 2024 | Hdfc Bank Limited | ₹3.50 M | Open |
How Many Employees Work at Innovus Meditech?
Unlock and access historical data on people associated with Innovus Meditech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Innovus Meditech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Innovus Meditech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
